N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic SchizophreniaMehdi Farokhnia, Shahin Akhondzadeh, Bahman Salehi et al.|Clinical Neuropharmacology|2013Cited by 154
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled studyShahin Akhondzadeh, Omid Mirshafiee, Mehdi Farokhnia et al.|Psychiatry Research|2014Cited by 104
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trialAli Ghaleiha, Shahin Akhondzadeh, Mohammad Ghyasvand et al.|Journal of Psychopharmacology|2013Cited by 88
Oral Scopolamine Augmentation in Moderate to Severe Major Depressive DisorderDanial Khajavi, Shahin Akhondzadeh, Seyed-Hesammedin Abbasi et al.|The Journal of Clinical Psychiatry|2012Cited by 87